Moderna
MRNA
#1246
Rank
C$25.82 B
Marketcap
C$65.09
Share price
-0.80%
Change (1 day)
75.07%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -C$4.29 Billion

According to Moderna 's latest financial reports the company's current earnings are C$2.20 Billion. In 2025 the company made an earning of -C$3.81 Billion, an increase over its 2024 earnings that were of -C$4.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$4.29 Billion12.67%
2025 -C$3.81 Billion-23.03%
2024 -C$4.95 Billion-8.22%
2023 -C$5.39 Billion-140.65%
2022 C$13.24 B-27.81%
2021 C$18.34 B-1911.15%
2020 -C$1.02 Billion44.7%
2019 -C$0.71 Billion28.63%
2018 -C$0.55 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$35.83 B-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$21.77 B-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$18.14 B-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-C$65.42 Million-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$57.61 Million-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.19 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$0.47 B-111.09%๐Ÿ‡บ๐Ÿ‡ธ USA